Recomendaciones en el tratamiento de la enfermedad tromboembólica venosa en pacientes con infección por COVID-19

Abstract

Since the beginning of the COVID-19 pandemic there has been many reports regarding venous and arterial thrombotic complications in patients infected with the SARS-CoV-2 virus, however the exact mechanisms for patients with COVID-19 to develop hypercoagulability states are still unknown. Prophylactic anticoagulation is considered a fundamental strategy to avoid the aforementioned complications. The objective of the present review is to guide the treatment of thromboembolic venous disease in hospitalized patients infected with SARS-CoV-2. The present article aims to review on specific recommendations of thromboembolic prophylaxis for the treatment of venous thrombotic disease in COVID-19 hospitalized patients. Hence, we differentiate between critically and non-critically ill patients as well as the duration of treatment and the recommended strategies when discharging these patients. There is still uncertainty regarding treatment options for the aforementioned complications, until an effective strategy is found, international recommendations are our best option to follow.